Rogers Corp. Dl 1 Stock
€114.00
Your prediction
Financial data and news for Roger
sharewise wants to provide you with the best news and tools for Roger, so we directly link to the best financial data sources.
Financials
News
iRadimed Q2 Earnings Call Highlights
Key Points
- Interested in iRadimed Corporation? Here are five stocks we like better.
- iRadimed’s new 3870 pump is seeing strong demand: Second-quarter bookings exceeded shipments by more than
Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead
Key Points
- Interested in Avalyn Pharma Inc.? Here are five stocks we like better.
- Avalyn Pharma is pursuing inhaled versions of approved pulmonary fibrosis drugs to reduce side effects that
AEVEX Q1 Earnings Call Highlights
Key Points
- Interested in AEVEX Corp.? Here are five stocks we like better.
- Revenue and profit surged in AEVEX’s first quarter, with revenue up 307% year over year to $216.7 million and net
C&C Group H2 Earnings Call Highlights
Key Points
- Interested in C&C Group plc? Here are five stocks we like better.
- C&C Group’s FY 2026 results were weaker as group revenue fell 6% and operating profit before exceptional items
Ur Energy Q1 Earnings Call Highlights
Ur Energy (NYSEAMERICAN:URG) said production momentum improved at its Lost Creek uranium operation during the first quarter of 2026 and that its
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It
Roger E. Susi, CEO, President, and Chairman of IRADIMED CORPORATION (NASDAQ:IRMD), reported the indirect sale of 7,500 shares of common stock across multiple open-market transactions on May 26, 2026
Iradimed’s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors?
Roger E. Susi, Founder, CEO, President, and Chairman of Iradimed Corporation (NASDAQ:IRMD), reported the indirect sale of 7,500 shares of common stock over multiple transactions on May 18 and May
Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors.
Roger E. Susi, CEO, President, and Chairman of Iradimed Corporation (NASDAQ:IRMD), reported the indirect sale of 7,500 shares of common stock across multiple open-market transactions on April 20 and
Liquidia's (LQDA) CEO Sells 53,000 Shares for $2.1 Million
Roger Jeffs, Chief Executive Officer of Liquidia, disclosed the indirect sale of 53,300 shares of common stock through Serendipity BioPharma LLC, generating approximately $2.14 million in proceeds